Ascl2 and 11p15.5 amplification in colorectal cancer

Gut

Volumn 60, Issue 11, 2011, Pages 1606-1607

  Jubb, Adrian M ^a   Hoeflich, Klaus P ^b   Haverty, Peter M ^b   Wang, Jennifer ^b   Koeppen, Hartmut ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WNT PROTEIN;

ASCL2 GENE; CARCINOGENESIS; CHROMOSOME 11P; COLORECTAL CANCER; GENE AMPLIFICATION; GENE EXPRESSION; LETTER; LIVER METASTASIS; MICROARRAY ANALYSIS; ONCOGENE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CHROMOSOMES, HUMAN, PAIR 11; COLORECTAL NEOPLASMS; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LIVER NEOPLASMS;

EID: 80053572391     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.231746     Document Type: Letter

References (4)

1. Stange DE, Engel F, Longerich T, et al. Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain. Gut 2010;59:1236-44.
2. Jubb AM, Chalasani S, Frantz GD, et al. Achaetescute like 2 (ascl2) is a target of Wnt signalling and is upregulated in intestinal neoplasia. Oncogene 2006;25:3445-57. (Pubitemid 43877047)
3. Jubb AM, Zhong F, Bheddah S, et al. EphB2 is a prognostic factor in colorectal cancer. Clin Cancer Res 2005;11:5181-7. (Pubitemid 41003704)
4. Haverty PM, Fridlyand J, Li L, et al. High-resolution genomic and expression analyses of copy number alterations in breast tumors. Genes Chromosomes Cancer 2008;47:530-42. (Pubitemid 351657188)